Medibank Private Limited (ASX:MPL)
Australia · Delayed Price · Currency is AUD 5.21
+0.01 (0.19%)
Aug 11, 2026, 4:10 PM AEST
Medibank Private Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Premiums & Annuity Revenue | 8,194 | 8,012 | 7,623 | 7,086 | 6,881 | 6,691 |
Total Interest & Dividend Income | 158.6 | 176.1 | 164.3 | 108.2 | 55.9 | 51 |
Gain (Loss) on Sale of Investments | 32.4 | 33.8 | 19.5 | 30.4 | -80.7 | 69 |
Other Revenue | 385.3 | 334.7 | 222.8 | 173.3 | 248.3 | 221.1 |
| 8,770 | 8,556 | 8,030 | 7,398 | 7,105 | 7,032 | |
Revenue Growth | 2.50% | 6.56% | 8.53% | 4.13% | 1.03% | 3.73% |
Policy Benefits | 6,843 | 6,655 | 6,289 | 6,057 | 5,680 | 5,558 |
Depreciation & Amortization | - | - | - | - | 115 | 122 |
Selling, General & Administrative | 674.4 | 656.6 | 619.5 | 566.6 | 290.4 | 281.5 |
Other Operating Expenses | 547.9 | 494.2 | 396.7 | 333.5 | - | - |
Total Operating Expenses | 8,065 | 7,806 | 7,306 | 6,957 | 6,547 | 6,396 |
Operating Income | 704.9 | 750.8 | 724.2 | 441.1 | 557.9 | 636.1 |
Interest Expense | -11.7 | -11 | -5.4 | -1.8 | -2.4 | -2.8 |
Earnings From Equity Investments | -12.8 | -11 | -7.1 | -1.4 | 4.5 | -1 |
EBT Excluding Unusual Items | 680.4 | 728.8 | 711.7 | 437.9 | 560 | 632.3 |
Pretax Income | 680.4 | 728.8 | 711.7 | 437.9 | 560 | 632.3 |
Income Tax Expense | 208.1 | 219.5 | 215.3 | 129.3 | 166.1 | 191.1 |
Earnings From Continuing Ops. | 472.3 | 509.3 | 496.4 | 308.6 | 393.9 | 441.2 |
Net Income to Company | 472.3 | 509.3 | 496.4 | 308.6 | 393.9 | 441.2 |
Minority Interest in Earnings | -8.9 | -8.5 | -3.9 | - | - | - |
Net Income | 463.4 | 500.8 | 492.5 | 308.6 | 393.9 | 441.2 |
Net Income to Common | 463.4 | 500.8 | 492.5 | 308.6 | 393.9 | 441.2 |
Net Income Growth | -7.47% | 1.69% | 59.59% | -21.65% | -10.72% | 40.06% |
Shares Outstanding (Basic) | 2,759 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 |
Shares Outstanding (Diluted) | 2,759 | 2,754 | 2,754 | 2,754 | 2,754 | 2,754 |
Shares Change | 0.17% | - | - | - | - | - |
EPS (Basic) | 0.17 | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 |
EPS (Diluted) | 0.17 | 0.18 | 0.18 | 0.11 | 0.14 | 0.16 |
EPS Growth | -7.62% | 1.69% | 59.59% | -21.65% | -10.72% | 40.06% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | 286 | 369.7 | 861.5 | 176.7 | 941.5 | 471.3 |
Free Cash Flow Per Share | 0.10 | 0.13 | 0.31 | 0.06 | 0.34 | 0.17 |
Dividend Per Share | 0.185 | 0.180 | 0.166 | 0.146 | 0.134 | 0.127 |
Dividend Growth | 2.78% | 8.43% | 13.70% | 8.96% | 5.51% | 5.83% |
Operating Margin | 8.04% | 8.77% | 9.02% | 5.96% | 7.85% | 9.05% |
Profit Margin | 5.28% | 5.85% | 6.13% | 4.17% | 5.54% | 6.27% |
Free Cash Flow Margin | 3.26% | 4.32% | 10.73% | 2.39% | 13.25% | 6.70% |
EBITDA | 722.2 | 768.6 | 738.1 | 454.2 | 571.2 | 654 |
EBITDA Margin | 8.24% | 8.98% | 9.19% | 6.14% | 8.04% | 9.30% |
D&A For EBITDA | 17.3 | 17.8 | 13.9 | 13.1 | 13.3 | 17.9 |
EBIT | 704.9 | 750.8 | 724.2 | 441.1 | 557.9 | 636.1 |
EBIT Margin | 8.04% | 8.77% | 9.02% | 5.96% | 7.85% | 9.05% |
Effective Tax Rate | 30.59% | 30.12% | 30.25% | 29.53% | 29.66% | 30.22% |